Aardvark Therapeutics Inc. Common Stock
AARD | NASDAQ
$5.73
+$0.16 (+2.87%)
Sep 22, 2026, 10:58 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -14.39M | -21.59M | -17.6M | -16.32M | -14.37M | -9.31M | -8.78M | -4.18M | -5.45M | -2.18M | -2.04M | -2.11M |
Depreciation & Amortization | 11K | -118K | 10K | 10K | -620K | 5K | -121K | 87K | 48K | 2K | 25K | 26K |
Stock-Based Compensation | 1.95M | 2M | n/a | n/a | 634K | 233K | 173K | 145K | 54K | 67K | 69K | 72K |
Other Working Capital | -427K | -1.7M | 1.7M | -387K | 1.81M | -3.01M | -378K | 488K | 539K | 126K | -238K | -260K |
Other Non-Cash Items | -2.34M | 110K | 3.84M | -1.21M | 124K | 41K | 185K | 91K | -41K | 238K | 97K | 742K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.83M | 723K | -673K | -999K | 4.39M | -2.36M | 815K | -96K | 1.17M | -319K | 694K | -316K |
Operating Cash Flow | -17.6M | -18.87M | -14.42M | -18.52M | -9.84M | -11.39M | -7.73M | -3.96M | -4.22M | -2.19M | -1.16M | -1.59M |
Capital Expenditures | n/a | n/a | n/a | -4K | -91K | n/a | -6K | -5K | -93K | -5K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -4.95M | n/a | n/a | -124.65M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 28.75M | 34.25M | 29.25M | 29.25M | 9.5M | 12.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -11.89M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 28.75M | 34.25M | 24.3M | 29.25M | 9.41M | -112.62M | -11.9M | -5K | -93K | -5K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -1.18M | 64K | 82.94M | n/a | n/a | n/a |
Financial Cash Flow | 262K | 4K | -2.11M | 2.56M | -71K | 88.88M | -1.01M | 64K | 82.94M | n/a | n/a | n/a |
Net Cash Flow | 11.41M | 15.39M | 7.77M | 13.29M | -506K | -35.14M | -20.64M | -3.9M | 78.63M | -2.2M | -1.16M | -1.59M |
Free Cash Flow | -17.6M | -18.87M | -14.42M | -18.52M | -9.94M | -11.39M | -7.73M | -3.96M | -4.31M | -2.2M | -1.16M | -1.59M |
Adj. Free Cash Flow | -19.55M | -20.87M | -14.42M | -18.52M | -10.57M | -11.62M | -7.91M | -4.11M | -4.36M | -2.26M | -1.23M | -1.66M |
Maintenance CapEx | n/a | n/a | n/a | -4K | -91K | n/a | -6K | -5K | -48K | -2K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -45K | -3K | n/a | n/a |
Owner Earnings | -17.6M | -18.87M | -14.42M | -18.52M | -9.94M | -11.39M | -7.73M | -3.96M | -4.26M | -2.19M | -1.16M | -1.59M |
Add to Watchlist
Select watchlists to add or remove AARD